stockrowStryker Corporation
SYK Healthcare Medical Devices
Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024.
- Revenue
- +7.64%
- EPS
- −12.4%
- Free cash flow
- −19.4%
- Total debt
- −10.0%
Quarter to September 2026, against a year earlier
Follow SYK
Alert me
Stryker Corporation (SYK) Total debt
Stryker Corporation's total debt at the end of fiscal 2025 was $15.9B, up 16.6% from $13.6B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $14.9B. Over the past ten years it has ranged from $4.0B (fiscal 2015) to $15.9B (fiscal 2025) — the current reading is the highest in ten years. Stryker Corporation ranks 3rd of 147 Medical Devices companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $15.9B | 16.64% |
| FY2024 | $13.6B | 4.63% |
| FY2023 | $13.0B | (0.41%) |
| FY2022 | $13.0B | 4.56% |
| FY2021 | $12.5B | (10.81%) |
| FY2020 | $14.0B | 26.16% |
| FY2019 | $11.1B | 12.49% |
| FY2018 | $9.9B | 36.51% |
| FY2017 | $7.2B | 4.45% |
| FY2016 | $6.9B | 72.94% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $14.9B | (0.08%) |
| Jun 2026 | $14.9B | 1.49% |
| Mar 2026 | $14.7B | (7.16%) |
| Dec 2025 | $15.9B | (4.44%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| ABT Abbott Laboratories compare | $32.6B |
| MDT Medtronic PLC compare | $28.2B |
| SYK Stryker Corporation | $14.9B |
| BSX Boston Scientific Corporation compare | $12.0B |
| GEHC GE HealthCare Technologies Inc. compare | $11.6B |
| PHG Koninklijke Philips N.V. compare | $8.0B |
| STE STERIS plc compare | $1.9B |
| DXCM DexCom, Inc. compare | $1.2B |
| EW Edwards Lifesciences Corporation compare | $598.8M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on SYK
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement